In addition, we investigated the level of tumor tertiary lymphoid structure (TLS)-related genes between the low/high-risk group according to previous reports26, and the results indicated that the level of CCL2, CCL3, CCL4, as well as CCL19 was lower in the high-risk group than in the low-risk group (Fig. 8I). This evidence concerns the gene CCL2 and neoplasm.